This site uses cookies and similar technologies.

If you do not change your browser settings, then you agree to their use

I understand
about-us1

About us

A dynamic, modern business providing quality medicines in the most cost effective and efficient manner

Read more >

Partnerships

Proud to partner with the NHS and exceptional businesses in the UK and around the world

Read more >
products2

Products

Explore our expanding portfolio of products across a broad range of therapeutic areas

Read more >

Headline brands

A collection of ambassador products that demonstrate our ethos – providing quality medicines tailored to patients’ and providers’ needs

Read more >

 

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare and its subsidiaries, including Morningside Healthcare (India) creating the UK’s premier Specialty Pharma company. To read more please click here

 

MORNINGSIDE HEALTHCARE IS PLEASED TO ANNOUNCE THE LAUNCH OF FLUORIDE TOOTHPASTE

 

Morningside Healthcare is pleased to announce the launch of Fluoride Toothpaste. The first licensed generic formulation of Fluoride Toothpaste currently available in the UK.

 

Morningside Healthcare's Fluoride toothpaste is available as Fluoride 2800ppm Toothpaste (75ml tube) and Fluoride 5000ppm Toothpaste (51g tube). Stocks are available from all full line wholesalers from June 2015.

 

Product

 Pack Size PIP Code EAN Code
Fluoride 2800ppm Toothpaste 75ml tube 1203231 5055132715297
Fluoride 5000ppm Toothpaste 51g tube 1203249 5055132715303

 

For further sales information please contact customer services on 01509 217705 or email This email address is being protected from spambots. You need JavaScript enabled to view it.
 
For medical enquiries please contact medical information on +44 (0) 116 478 0322.

 

Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.

MHL_1_21.06.2023 | Date of preparation: June 2023